Antonio Santo

1.5k total citations
55 papers, 786 citations indexed

About

Antonio Santo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Antonio Santo has authored 55 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Antonio Santo's work include Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Research Studies (23 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Antonio Santo is often cited by papers focused on Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Research Studies (23 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Antonio Santo collaborates with scholars based in Italy, United States and Malaysia. Antonio Santo's co-authors include Gianluigi Cetto, Felice Pasini, Marco Chilosi, Emilio Bria, Giampaolo Tortora, Sara Pilotto, Gian Luigi Cetto, Matteo Brunelli, Aldo Scarpa and A. Farris and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Antonio Santo

54 papers receiving 761 citations

Peers

Countries citing papers authored by Antonio Santo

Since Specialization

Citations

This map shows the geographic impact of Antonio Santo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Santo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Santo more than expected).

Fields of papers citing papers by Antonio Santo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Santo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Santo. The network helps show where Antonio Santo may publish in the future.

Co-authorship network of co-authors of Antonio Santo

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Santo. A scholar is included among the top collaborators of Antonio Santo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Santo. Antonio Santo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification and Characterization of Immune Checkpoint Inhibitor–Induced Toxicities From Electronic Health Records Using Natural Language Processing 2024 ·JCO Clinical Cancer Informatics ·(unknown), Sriram Venkateswaran, Antonio Santo, (unknown), Eli Silvert, Krishna Rao, (unknown), Lisa A. Kottschade, Matthew S. Block, G. Scott Chandler, (unknown), (unknown), (unknown)	6
2	1786O BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin + etoposide + nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis (IA) of a randomized phase II study 2024 ·Annals of Oncology ·Ewa Kalinka‐Warzocha, (unknown), (unknown), (unknown), (unknown), (unknown), Alain Sibille, Mariano Provencio, (unknown), J.T.J.N. Hiltermann, T-E. Ciuleanu, Rafał Dziadziuszko, Antonio Santo, (unknown), Yunpeng Liu, (unknown), (unknown), Laureen S. Ojalvo, Jindao Wu, Kenneth J. O’Byrne	1
3	Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome 2020 ·ESMO Open ·Ilaria Trestini, Isabella Sperduti, Marco Sposito, (unknown), (unknown), Alice Avancini, Daniela Tregnago, Luisa Carbognin, Chiara Bovo, Antonio Santo, Massimo Lanza, Mirko D’Onofrio, Giampaolo Tortora, Emilio Bria, Michèle Milella, Sara Pilotto	15
4	P3.08-04 OMEGA, A Randomized Trial of Local Ablative Therapy Vs. Conventional Treatment in Oligometastatic NSCLC – Trial in Progress 2018 ·Journal of Thoracic Oncology ·Maurizio Infante, Emilio Bria, Silvia Novello, Ugo Pastorino, L Buffoni, Marta Scorsetti, Marco Alloisio, Andrea Ardizzoni, Antonio Santo, Sara Pilotto, Francesco Facciolo, Diana Giannarelli	1
5	Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis 2018 ·Clinical & Translational Oncology ·Andrea Camerini, Giuseppe Luigi Banna, Saverio Cinieri, Aldo Pezzuto, Manlio Mencoboni, Francesco Rosetti, Arnaldo Figueiredo, P. Rizzo, Alberto Rícci, (unknown), Antonio Santo, Alfredo Addeo, D. Amoroso, Fernando Barata	22
6	LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab 2017 ·Clinical Cancer Research ·Laura Bonanno, Angela De Paoli, Elisabetta Zulato, Giovanni Esposito, Fiorella Calabrese, Adolfo Favaretto, Antonio Santo, Alessandro Del Conte, Marco Chilosi, Francesco Oniga, Gabriella Sozzi, Massimo Moro, Francesco Ciccarese, Giorgia Nardo, Roberta Bertorelle, Cinzia Candiotto, Gian Luca De Salvo, Alberto Amadori, Pierfranco Conté, Stefano Indraccolo	39
7	Efficacy and safety data from patients with advanced non-squamous NSCLC and brain metastases from the nivolumab expanded access programme (EAP) in Italy 2017 ·Annals of Oncology ·Lucio Crinò, Paolo Bidoli, F. Roila, Enrico Cortesi, Marina Chiara Garassino, Federico Cappuzzo, Francesco Grossi, Giuseppe Tonini, (unknown), G. Pinotti, Gianmauro Numico, (unknown), L. Ciuffreda, Antonio Frassoldati, Marco Bregni, Antonio Santo, Francovito Piantedosi, (unknown), Filippo de Marinis, Angelo Delmonte	4
8	Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study 2017 ·Journal of Cancer Research and Clinical Oncology ·Maria Rita Migliorino, Antonio Santo, Giampiero Romano, Diego Cortinovis, Domenico Galetta, Oscar Alabiso, Giacomo Cartenì, Sabrina Vari, Gianpiero Fasola, Antonio Pazzola, Dario Giuffrida, Alberto Zaniboni, (unknown), Flavia Longo, (unknown), Filippo de Marinis	36
9	Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment 2017 ·Journal of Thoracic Oncology ·Sara Pilotto, Isabella Sperduti, Giovanni Leuzzi, Marco Chiappetta, Felice Mucilli, Giovanni Battista Ratto, Filippo Lococo, (unknown), Lorenzo Spaggiari, Silvia Novello, Michèle Milella, Antonio Santo, Aldo Scarpa, Maurizio Infante, Giampaolo Tortora, Francesco Facciolo, Emilio Bria	13
10	ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 2016 ·Respiratory Research ·Umberto Peretti, Roberto Ferrara, Sara Pilotto, Stefania Kinspergher, Mario Caccese, Antonio Santo, Matteo Brunelli, Anna Caliò, Luisa Carbognin, Isabella Sperduti, Marina Chiara Garassino, Marco Chilosi, Aldo Scarpa, Giampaolo Tortora, Emilio Bria	9
11	77P Glycolytic marker monocarboxylate transporter 4 (MCT4) and outcome to bevacizumab (bev): An exploratory analysis in advanced non-small cell lung cancer (A-NSCLC) 2016 ·Journal of Thoracic Oncology ·Laura Bonanno, Fiorella Calabrese, Angela De Paoli, Giulia Pasello, Antonio Santo, Adolfo Favaretto, Marco Chilosi, Alessandro Del Conte, Pierfranco Conté, Stefano Indraccolo	1
12	ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 2014 ·Journal of Thoracic Oncology ·Anna Caliò, Alessia Nottegar, Eliana Gilioli, Emilio Bria, Sara Pilotto, Umberto Peretti, Stefania Kinspergher, Francesca Simionato, Serena Pedron, Sakari Knuutila, Giampaolo Tortora, Albino Eccher, Antonio Santo, Luca Tondulli, Giorgio Inghirami, Fabrizio Tabbò, Guido Martignoni, Marco Chilosi, Aldo Scarpa, Matteo Brunelli	46
13	Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study 2014 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Cesare Gridelli, Filippo de Marinis, Andrea Ardizzoni, Silvia Novello, Gabriella Fontanini, Federico Cappuzzo, Francesco Grossi, Antonio Santo, Diego Cortinovis, Adolfo Favaretto, Vito Lorusso, Domenico Galetta, Salvatore Siena, Anna Bettini, Monica Iurlaro, (unknown)	9
14	Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis 2009 ·Medical Oncology ·Maria Bonomi, Rolando Nortilli, (unknown), Teodoro Sava, Antonio Santo, A. Caldara, Gianluigi Cetto	21
15	Survival Following Complete Resection of Multifocal T4 Node-Negative NSCLC: A Retrospective Study 2007 ·The Thoracic and Cardiovascular Surgeon ·Alberto Terzi, (unknown), (unknown), Giovenzio Genestreti, Antonio Santo, (unknown), (unknown), Fabio Calabrò	5
16	Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients 2006 ·Lung Cancer ·Antonio Santo, Giovenzio Genestreti, Alberto Terzi, Paolo Azzoni, Teodoro Sava, (unknown), Annamaria Molino, Cristian Pattaro, Rocco Micciolo, Gian Luigi Cetto	6
17	Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC) 2006 ·Annals of Oncology ·Antonio Santo, Giovenzio Genestreti, Teodoro Sava, (unknown), Alberto Terzi, A. Molino, Gian Luigi Cetto	8
18	Completion pneumonectomy for non-small cell lung cancer: experience with 59 cases 2002 ·European Journal of Cardio-Thoracic Surgery ·Alberto Terzi, (unknown), (unknown), Paolo Scanagatta, Antonio Santo, G Furlan, Fabio Calabrò	20
19	A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis 2001 ·Lung Cancer ·Antonio Santo, Rebecca Pedersini, Felice Pasini, Alberto Terzi, (unknown), G. Cartei, (unknown), (unknown), (unknown), N. Panza, (unknown), Sergio Maluta, Fabio Calabrò, Gian Luigi Cetto	13
20	Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen: A phase II study 1996 ·Cancer ·Diego Tummarello, Francesco Graziano, (unknown), Antonio Santo, Gianluigi Cetto, Anna Fedeli, G. Rossi, R. Cellerino	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact